Multicenter randomized comparative study of photodynamic therapy and ranibizumab therapy for the visual acuity improvement in patient with polypoidal choroidal vasculopathy.

Trial Profile

Multicenter randomized comparative study of photodynamic therapy and ranibizumab therapy for the visual acuity improvement in patient with polypoidal choroidal vasculopathy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 May 2016

At a glance

  • Drugs Ranibizumab (Primary)
  • Indications Age-related macular degeneration
  • Focus Therapeutic Use
  • Acronyms LAPTOP
  • Most Recent Events

    • 11 Dec 2015 New trial record
    • 01 Oct 2013 Interim results (12 months) published in the American Journal of Ophthalmology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top